2013
DOI: 10.1155/2013/636050
|View full text |Cite
|
Sign up to set email alerts
|

Alternative Splicing Regulation of Cancer-Related Pathways inCaenorhabditis elegans: An In Vivo Model System with a Powerful Reverse Genetics Toolbox

Abstract: Alternative splicing allows for the generation of protein diversity and fine-tunes gene expression. Several model systems have been used for the in vivo study of alternative splicing. Here we review the use of the nematode Caenorhabditis elegans to study splicing regulation in vivo. Recent studies have shown that close to 25% of genes in the worm genome undergo alternative splicing. A big proportion of these events are functional, conserved, and under strict regulation either across development or other condit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2015
2015
2017
2017

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 90 publications
(104 reference statements)
0
2
0
Order By: Relevance
“…Roughly 25% of protein-coding genes in C. elegans have multiple isoform annotations, with each gene producing 2.2 isoforms on average (Ramani et al 2011). In addition, many C. elegans trans-acting alternative splicing factors and their targeted cis-elements are conserved in mammals, making these worms an excellent model organism to study human diseases related to splicing factors (Kabat et al 2006;Zahler 2012;Barberan-Soler and Ragle 2013). The 5 ′ splice site consensus sequence in C. elegans is similar to other eukaryotes.…”
mentioning
confidence: 99%
“…Roughly 25% of protein-coding genes in C. elegans have multiple isoform annotations, with each gene producing 2.2 isoforms on average (Ramani et al 2011). In addition, many C. elegans trans-acting alternative splicing factors and their targeted cis-elements are conserved in mammals, making these worms an excellent model organism to study human diseases related to splicing factors (Kabat et al 2006;Zahler 2012;Barberan-Soler and Ragle 2013). The 5 ′ splice site consensus sequence in C. elegans is similar to other eukaryotes.…”
mentioning
confidence: 99%
“…Its biological qualities can allow the improvement of the visibility and understanding of pathological diseases in humans and other multicellular beings. Some of the advantages of using C. elegans as a model for experimentation in vivo in this study are: Its perceptible phenotypes, the visibility of their internal organs, short life cycle (3 weeks), and the ability to adapt to different conditions in the laboratory [8] , [9] .…”
Section: Introductionmentioning
confidence: 99%